SCHEMBL7652985

SCHEMBL7652985

CCCCc1nc(C(c2ccc(-c3ccccc3/C=C3\NC(=O)CC3=O)cc2)c2cccs2)n[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7650688 0.90 AGTR1 (0.32)
SCHEMBL7658315 0.90 GSK3B (0.31)
SCHEMBL7654107 0.88 APLNR (0.32)
SCHEMBL7661069 0.87
SCHEMBL7654385 0.86
SCHEMBL7657723 0.86 APLNR (0.32)
SCHEMBL7660683 0.83 APLNR (0.31)
SCHEMBL7656066 0.83 BRS3 (0.33)
SCHEMBL7927328 0.82 DDX3X (0.32)
SCHEMBL7652695 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358984-B1 FOR THERAPY OF HYPERTENSION AND/OR DISEASES SUCH AS HEART AND RENAL DISEASES LEAD CHEMICAL CO., LTD. (JP) 2002-03-19 US disclosed
US-6232335-B1 A BIPHENYL TRIAZOLE COMPOUND USEFUL AS A ANGIOTENSIN II CONVERTING ENZYME INHIBITORS EFFECTIVE IN THE TREATMENT OF HYPERTENSION OR HEART FAILURE LEAD CHEMICAL CO., LTD. (JP) 2001-05-15 US disclosed